MAPT and Alzheimer disease: Because previous research had identified the targeted plasma proteins as candidate biomarkers of AD pathology, we next performed a correlation analyses between these proteins with CSF Aβ and with CSF T-tau and P-tau measures to determine whether their biomarker ability replicated in this cognitively healthy cohort.